Personalized antibiotic dosing for ICU patients
Part of Infections clinical trials.
This trial tests a new way to quickly measure antibiotic levels in the blood of ICU patients, so doctors can adjust the dose for each person. It aims to make antibiotic therapy more effective and safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being treated in the intensive care unit (ICU) or intermediate care unit of the general surgery department at UMG.
- You are currently receiving a beta-lactam antibiotic (a common type of antibiotic used for serious infections).
- You (or your legal representative) have signed a consent form agreeing to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a new blood test (called BV test) to help doctors decide if antibiotics should be stopped or continued for ICU patients with suspected or confirmed infections. It aims to reduce unnecessary antibiotic use while keeping patients safe.
This study tests whether quickly identifying the exact bacteria causing your lung infection and using special computer models to choose the best antibiotic dose can improve your recovery in the ICU. It aims to make antibiotic treatment more personalized and effective.
This trial checks if giving higher doses of beta-lactam antibiotics (a type of strong antibiotic) right from the start helps people in the ICU with septic shock. It aims to find the best dose to fight the infection quickly.
This study looks at how doctors can better monitor antibiotic levels in the blood of intensive care patients with severe infections (sepsis or septic shock). The goal is to see if adjusting antibiotic doses based on these levels improves recovery.
This trial tests a method to check antibiotic levels in the blood of very sick patients with sepsis. The goal is to see if adjusting the dose based on these levels helps recovery.
This trial tests a personalized dosing approach for certain antibiotics (amoxicillin-clavulanic acid, piperacillin-tazobactam, and meropenem) in hospitalized children with serious infections. The goal is to adjust the dose based on blood tests to make sure each child gets the right amount of medicine.
Hear when a new Bacterial Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.